The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study

Size: px
Start display at page:

Download "The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study"

Transcription

1 The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal University of Rio de Janeiro June 1, 2006

2 Rio de Janeiro ICIDR Program Community randomized trial of 2 TB prevention strategies Randomized trial of two TB chemoprevention strategies Novel diagnostic techniques for TB and TB drug resistance

3 Rio de Janeiro ICIDR Program Community randomized trial of 2 TB prevention strategies Randomized trial of two TB chemoprevention strategies Novel diagnostic techniques for MODS TB and TB drug resistance Study

4 What is MODS? microscopic observation drug susceptibility Pioneered by Robert Gilman in Peru Liquid culture method for detection of M. tuberculosis Microscopic detection of bacterial cording that is characteristic for M. tuberculosis Can be adapted for drug susceptibility testing Relatively simple, relatively inexpensive, no radioactivity

5 What is MODS? MODS assay culture plate cording of M. tuberculosis

6 Study Objectives To evaluate sensitivity and specificity of MODS for detection of M. tuberculosis in respiratory specimens from pulmonary TB suspects in disease endemic settings To evaluate the time to growth for M. tuberculosis in MODS versus Lowenstein-Jensen, and versus MGIT 960 To evaluate the sensitivity and specificity of MODS for direct detection of isoniazid and rifampin drug resistance At study sites, to increase capacity to evaluate new TB diagnostic tests using Good Laboratory Practices, and to facilitate South-South collaboration

7 Study Design Prospective, multicenter Federal University of Rio de Janeiro, Brazil Instituto Nacional del Torax, Honduras Respiratory specimens obtained from pulmonary TB suspects (~ 70% outpatients) Comparators Clinical diagnosis of TB (includes LJ culture results) Companion Lowenstein-Jensen culture Sample size 1655 respiratory specimens

8 Study Scheme respiratory specimen smear microscopy Lowenstein- Jensen culture MODS culture Direct MODS DST isoniazid rifampin MGIT culture Indirect LJ DST isoniazid rifampin

9 Characteristics of 854 Study Subjects (adult pulmonary TB suspects) Characteristic # % Brazil Honduras Male Female Type of Subject New TB suspect Suspected TB relapse Suspected TB treatment failure Suspected TB treatment defaulter HIV positive HIV negative HIV not tested

10 Characteristics of 1639 Study Specimens Characteristic # % Brazil Honduras Expectorated sputum Induced sputum Bronchoalveolar lavage/bronch wash

11 Overall Results (by specimen) # % AFB smear positive LJ culture positive for M. tuberculosis MODS culture positive for M. tuberculosis LJ culture positive for NTM

12 Proportions of contaminated cultures for Lowenstein-Jensen and MODS % contaminated p < % LJ MODS

13 Performance characteristics of MODS for detection of TB TB Diagnosis Companion LJ Sensitivity (%) 97.5* 96.5 Specificity (%) PPV (%) NPV (%) Agreement (%) N/A 94.2 *LJ sensitivity 98.9% difference 1.4%, 95% CI -0.5 to 2.7; p=0.27

14 Time to growth for culture positive specimens, by culture method Days to growth of M. tuberculosis For LJ and MODS: N=657 specimens p < For MGIT: N=64 specimens p = 0.16 for MODS vs MGIT LJ MODS MGIT

15 Time to growth, by culture method and smear microscopy status % positive for growth Smear negative, N=135 Smear positive, N=522 LJ, smear negative MODS, smear negative LJ, smear positive MODS, smear positive Days to M. tuberculosis grow th

16 Overall Drug Susceptibility Test Results Lowenstein-Jensen Result # % Susceptible to INH and RIF INH resistant RIF susceptible INH susceptible RIF resistant Resistant to INH and RIF N = 188 study subjects having risk factor(s) for drug resistant TB

17 Performance characteristics of MODS for detection of drug resistance Isoniazid Rifampin Sensitivity (%) Specificity (%) PPV (%) NPV (%) Agreement (%) Comparator: Lowenstein-Jensen N=188 subjects with risk factor(s), and positive LJ and MODS cx

18 Summary For diagnosis of pulmonary TB, MODS has good sensitivity, which is similar to that of LJ MODS has an acceptable contamination rate Time to detection of MODS growth is about one-third that of LJ, and similar to MGIT MODS identifies as TB some non-tuberculous mycobacteria MODS is sensitive for detection of isoniazid or rifampin resistance MODS indicates as resistant some cultures that are susceptible to INH or rifampin MODS performed similarly at both study sites

19 Conclusions Rapidity of growth and low contamination rates make MODS an attractive platform Inability to accurately differentiate M. tuberculosis from some non-tuberculous mycobacteria may be problematic in some settings Good sensitivity, high NPV, and short turnaround time of MODS for direct detection of INH and/or RIF resistance might make MODS suitable as a screening test in order to prioritize isolates for subsequent confirmatory indirect testing using conventional methods

20 Acknowledgements Federal Univ of Rio de Janeiro Fernanda Mello Anna Grazia Marsico Leo Pessoa Monica Andrade Leila Fonseca Afranio Kritski Johns Hopkins University Richard Chaisson National Thorax Institute, Honduras Ada Pavon Carlos Alvarado-Galvez Senia Rosales Melly Perez University of Alabama Mayra Arias Michael Kimerling NIH / DMID USAID

21 Laboratory Methods Respiratory specimens were obtained from TB suspects undergoing evaluation for TB Specimens were processed using a NALC-NaOH method of decontamination/mucolysis LJ culture and indirect drug susceptibility testing for INH and RIF were performed according to published standards 0.2 ml each processed respiratory specimen was inoculated into 1 ml of MODS/PANTA 7H9-based liquid media, and into 1 ml of MODS/PANTA medium containing para-nitrobenzoic acid For MODS direct drug susceptibility testing, INH concentration was 0.1 ug/ml, and RIF concentration was 2.0 ug/ml. MODS wells were observed microscopically under 40X magnification at a frequency of twice weekly For LJ cultures, standard biochemical tests were used to determine mycobacterial species For MODS cultures, cording morphology and absence of growth in PNB were considered diagnostic of M. tuberculosis

Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis

Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis MAJOR ARTICLE Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis Mayra Arias, 1,a Fernanda C. Q. Mello, 4,a Ada Pavón, 5 Anna Grazia Marsico, 4 Carlos

More information

Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis

Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt

More information

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,

More information

TB 101 Disease, Clinical Assessment and Lab Testing

TB 101 Disease, Clinical Assessment and Lab Testing TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain

More information

Ken Jost, BA, has the following disclosures to make:

Ken Jost, BA, has the following disclosures to make: Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict

More information

TB Laboratory for Nurses

TB Laboratory for Nurses TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant

More information

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral

More information

Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China

Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China Int J Clin Exp Pathol 2017;10(4):4847-4851 www.ijcep.com /ISSN:1936-2625/IJCEP0045802 Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China

More information

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria RESEARCH ARTICLE Open Access Journal of Infectious Diseases and Pathogenesis ISSN 577-7939 Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

Abstract. Introduction. Editor: M. Drancourt

Abstract. Introduction. Editor: M. Drancourt ORIGINAL ARTICLE BACTERIOLOGY Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis

More information

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant

More information

Receipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen

Receipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen Recommendation Promote rapid delivery of specimens to the laboratory Use fluorescent acid-fast staining and promptly transmit results by phone, FAX, or electronically Identify growth as acid-fast and use

More information

Comparative performance of emerging rapid diagnostics in HIV-infected individuals

Comparative performance of emerging rapid diagnostics in HIV-infected individuals Comparative performance of emerging rapid diagnostics in HIV-infected individuals Maunank Shah M.D. Johns Hopkins University Clinical Diagnostics Research Consortium Background Emerging diagnostics may

More information

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24 Diagnosis of extrapulmonaryand paediatric tuberculosis AW Dreyer Centre for Tuberculosis NICD Introduction Part of the global efforts to control tuberculosis (TB) include improving case detection, especially

More information

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%

More information

Stacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona

Stacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures

More information

Tuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka.

Tuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka. Bangladesh J Med Microbiol 2011; 05 (02): 06-10 Bangladesh Society of Medical Microbiologists Original Article A rapid Drug Susceptibility Test (DST) for detection of Multi-Drug Resistant (MDR) Mycobacterium

More information

Nucleic Acid Amplification Testing for the Diagnosis of TB

Nucleic Acid Amplification Testing for the Diagnosis of TB Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm

More information

Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients.

Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients. Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients. Item Type Thesis Authors Patel, Ravikumar Publisher The University of Arizona. Rights Copyright

More information

Clinical Diagnostics Research Consortium (CDRC)

Clinical Diagnostics Research Consortium (CDRC) Clinical Diagnostics Research Consortium (CDRC) Funded through a contract from U.S. National Institute of Allergy and Infectious Disease, National Institutes of Health Mission: to evaluate novel TB diagnostics

More information

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

Principles of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017

Principles of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017 Principles of laboratory diagnosis of M. tuberculosis Anne-Marie Demers, MD, FRCPC 11 September 2017 QUESTION Which statement is false? 1) A smear can only be on a concentrated specimen 2) It is normal

More information

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient

More information

Towards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures

Towards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures: Towards Harmonization of Mycobacteriology in TB Trials Title Author(s) Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory

More information

Diagnosis of drug resistant TB

Diagnosis of drug resistant TB Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million

More information

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility

More information

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant

More information

Characteristics of Mycobacterium

Characteristics of Mycobacterium Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to

More information

The ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory

The ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory The ABC s of AFB s Laboratory Testing for Tuberculosis Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory Laboratory TAT Goals Case Study Specimen Collection Testing Contact

More information

A retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece

A retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece Örebro University School of Health and Medical Science Biomedical Laboratory Science Programme 180 credits Degree project in biomedical laboratory science, advanced course, 15 credits May 21, 2015 A retrospective

More information

Objectives. TB Laboratory Methods

Objectives. TB Laboratory Methods TB Laboratory Methods Beverly Metchock, Dr.P.H., D(ABMM) Team Leader, Reference Laboratory, Mycobacteriology Laboratory Branch February 2011 Objectives General overview of mycobacteriology (TB) lab practices

More information

The Lancet Infectious Diseases

The Lancet Infectious Diseases Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E Dorman, Samuel G Schumacher, David Alland et al. 2017

More information

Biology and Medicine

Biology and Medicine eissn: 09748369 Diagnosis of pulmonary tuberculosis by smear microscopy and culture in a tertiary health care facility Biology and Medicine SI Khatib, MT Williamson, R Singh, JM Joshi Accepted: 28 th Feb

More information

Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection

Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection Author's response to reviews Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection Authors: Adithya Cattamanchi (acattamanchi@medsfgh.ucsf.edu)

More information

Standard Diagnostic Procedure for Tuberculosis: A Review

Standard Diagnostic Procedure for Tuberculosis: A Review ISSN: 2249 8656 www.stmjournals.com Standard Diagnostic Procedure for Tuberculosis: A Review Suresh Jaiswal*, Jay Prakash Sah, Bhoopendra Sharma Department of Medical Lab Science, School of Health and

More information

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH Akos Somoskövi, M.D., Ph.D. and Giorgio Roscigno, M.D. ANNUAL GLI MEETING, 4 th OCTOBER 2010 MERIEUX FOUNDATION, ANNECY Integrated Laboratory Network

More information

Public Health Mycobacteriology (TB) Laboratory Testing Services

Public Health Mycobacteriology (TB) Laboratory Testing Services Public Health Mycobacteriology (TB) Laboratory Testing Services Gary Budnick Supervising Microbiologist Connecticut Department of Public Health Laboratory Branch Hartford, Connecticut Specimen Collection

More information

TB NAAT testing at the Los Angeles County Public Health Laboratory

TB NAAT testing at the Los Angeles County Public Health Laboratory TB NAAT testing at the Los Angeles County Public Health Laboratory Hector Rivas Public Health Microbiology Supervisor II Los Angeles County Public Health Laboratory hrivas@ph.lacounty.gov April 2012 1

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis

Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 179 Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis complex,

More information

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH. The image part with relationship ID rid2 was not found in the file. MDR TB Management Review of the Evolution (or Revolution?) Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist,

More information

Diagnosis of tuberculosis

Diagnosis of tuberculosis Diagnosis of tuberculosis Madhukar Pai, MD, PhD Assistant Professor, Epidemiology McGill University, Montreal, Canada madhukar.pai@mcgill.ca Global TB Case Detection A major concern 2.6 million new smear

More information

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin

More information

EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY

EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY Indian Journal of Medical Microbiology, (2009) 27(3): 217-21 Original Article EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX IN A HIGH

More information

Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system

Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system Brazilian Journal of Medical and Biological Research (2002) 35: 1127-1131 MGIT detection of multidrug-resistant M. tuberculosis ISSN 0100-879X 1127 Rapid detection of multidrug-resistant Mycobacterium

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

New Standards for an Old Disease:

New Standards for an Old Disease: New Standards for an Old Disease: Practical Implications of the TB Standards TB Prevention and Control Saskatchewan September 16, 2015 Practical Implications of the TB Standards Learning Objectives At

More information

Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis

Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis YAM Wing-Cheong 任永昌 Department of Microbiology The University of Hong Kong Tuberculosis Re-emerging problem in industrialized countries

More information

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories

More information

Original Article INTRODUCTION. Abstract

Original Article INTRODUCTION. Abstract Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X Assessment for Performance of Middlebrook 7H9 with Oleic-Albumin-Dextrose-Catalase Culture Media for Isolation of Mycobacterium tuberculosis

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dorman S E, Schumacher S G, Alland D, et al.

More information

Mycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline

Mycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Mycobacteria Diagnostic Testing in Manitoba Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Acknowlegements: Assunta Rendina: Charge Tech HSC Lab Joyce Wolf & Dr. Meenu Sharma: NML Dr. Kanchana

More information

A comparative evaluation of mycobacteria growth indicator tube and Lowenstein-Jensen medium for the isolation of mycobacteria from clinical specimens

A comparative evaluation of mycobacteria growth indicator tube and Lowenstein-Jensen medium for the isolation of mycobacteria from clinical specimens Original Article Vol. 29 No. 2 Comparative evaluation of mycobacteria culture:-kaur KP, et al. 67 A comparative evaluation of mycobacteria growth indicator tube and Lowenstein-Jensen medium for the isolation

More information

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB / Dose Counting Rachel Munoz, RN. TB Nurse Case Manager/Nurse Consultant Austin/Travis County Health Department April 10, 2013 Rachel Munoz,

More information

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers

More information

SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT

SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT Original Article SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT R. Sarin 1, R. Singla 2, P. Visalakshi 3, A. Jaiswal 4, M.M. Puri 4, Khalid

More information

TB Prevention in PLHIV: Options Other Than Isoniazid. Johns Hopkins Center for Tuberculosis. Research. Richard E. Chaisson, MD

TB Prevention in PLHIV: Options Other Than Isoniazid. Johns Hopkins Center for Tuberculosis. Research. Richard E. Chaisson, MD TB Prevention in PLHIV: Options Other Than Isoniazid Johns Hopkins Center for Tuberculosis Richard E. Chaisson, MD Research Johns Hopkins University Center for Tuberculosis Research Consortium to Respond

More information

Mycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods

Mycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods Laboratory Methods Cell Cycle Lengths Generation time (hrs) Days needed for 26 generations (colony) E. coli 0.33 0.36 Nancy Connell, PhD Professor, nfectious Disease Department of Medicine Center for Emerging

More information

TB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012

TB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012 TB Nurse Case Management San Antonio, Texas March 7-9, 2012 Diagnosis of TB: Laboratory Ken Jost Wednesday March 7, 2012 Ken Jost has the following disclosures to make: No conflict of interests No relevant

More information

Multi-Site Performance Summary of. AEROSPRAY TB SLIDE STAINER/CYTOCENTRIFUGE (Model 7722)

Multi-Site Performance Summary of. AEROSPRAY TB SLIDE STAINER/CYTOCENTRIFUGE (Model 7722) Multi-Site Performance Summary of AEROSPRAY TB SLIDE STAINER/CYTOCENTRIFUGE (Model 7722) Abstract The new Aerospray TB Slide Stainer/Cytocentrifuge - Model 7722 (ELITechGroup Inc., www.elitechgroup.com)

More information

AFB Identification Texas Approach

AFB Identification Texas Approach AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175

More information

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

Pelin Yuksel*, Suat Saribas and Yasar Bagdatli

Pelin Yuksel*, Suat Saribas and Yasar Bagdatli African Journal of Microbiology Research Vol. 5(9), pp. 985-989, 4 May, 2011 Available online http://www.academicjournals.org/ajmr DOI: 10.5897/AJMR10.008 ISSN 1996-0808 2011 Academic Journals Full Length

More information

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Rapid Detection of Rifampin Resistance 江振源主任

Rapid Detection of Rifampin Resistance 江振源主任 101 年度最新結核病治療指引 醫師在職繼續教育系列 Rapid Detection of Rifampin Resistance 江振源主任 主辦單位 行政院衛生署國立臺灣大學傳染病防治研究及教育中心臺大醫院內科部 聯絡方式 電話 :02-33668260 網站 :http://ntuidrec.ntu.edu.tw Rapid detection of Rifampicin Resistance

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

Xpert MTB/RIF assay validation experience --- impact and plan in China

Xpert MTB/RIF assay validation experience --- impact and plan in China Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(5):

Int.J.Curr.Microbiol.App.Sci (2018) 7(5): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.239

More information

GLI Partners Meeting 18 th April Ivor Langley (LSTM) & Afrânio Kritski (Rede-TB)

GLI Partners Meeting 18 th April Ivor Langley (LSTM) & Afrânio Kritski (Rede-TB) Xpert MTB/RIF - Operational Research Initiatives GLI Partners Meeting 18 th April 212 Ivor Langley (LSTM) & Afrânio Kritski (Rede-TB) Agenda Introduction Example Initiatives Virtual Implementation Prove-IT

More information

TB BASICS: PRIORITIES AND CLASSIFICATIONS

TB BASICS: PRIORITIES AND CLASSIFICATIONS TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE NOVEMBER 1-4, 2016 TB BASICS: PRIORITIES AND CLASSIFICATIONS LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1.

More information

Rapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008

Rapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008 Tuberculosis Updates for Clinicians San Antonio, Texas November 13, 2008 Rapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008 Rapid Diagnostic Techniques for Identifying

More information

MYCOBACTERIA. Pulmonary T.B. (infect bird)

MYCOBACTERIA. Pulmonary T.B. (infect bird) MYCOBACTERIA SPP. Reservoir Clinical Manifestation Mycobacterium tuberculosis Human Pulmonary and dissem. T.B. M. lepra Human Leprosy M. bovis Human & cattle T.B. like infection M. avium Soil, water, birds,

More information

Assessing the programmatic management of drug-resistant TB

Assessing the programmatic management of drug-resistant TB Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many

More information

TB is Local. Barry Chin, Boston Globe, 10/15/2008. * BUT only in appropriate setting

TB is Local. Barry Chin, Boston Globe, 10/15/2008. * BUT only in appropriate setting Diagnosis of Tuberculosis 2012 New Tools, Tricks, Thinking? John Bernardo, M.D. Pulmonary Section, Boston University School of Medicine Massachusetts Department of Public Health Objectives To review the

More information

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million

More information

Community-Based Surveillance for Drug Resistance of Mycobacterium tuberculosis in Selected Areas in the Philippines

Community-Based Surveillance for Drug Resistance of Mycobacterium tuberculosis in Selected Areas in the Philippines Community-Based Surveillance for Drug Resistance of Mycobacterium tuberculosis in Selected Areas in the Philippines Myrna T. Mendoza, M.D.,* Tessa Tan-Torres, M.D.,* Concepcion F. Ang, R.M.T.,* Rosemarie

More information

Konjit Getachew, 1 Tamrat Abebe, 2 Abebaw Kebede, 3 Adane Mihret, 2,4 and Getachew Melkamu Introduction

Konjit Getachew, 1 Tamrat Abebe, 2 Abebaw Kebede, 3 Adane Mihret, 2,4 and Getachew Melkamu Introduction Tuberculosis Research and Treatment Volume 2015, Article ID 794064, 6 pages http://dx.doi.org/10.1155/2015/794064 Research Article Performance of LED Fluorescence Microscopy for the Diagnosis of Pulmonary

More information

TB prevention studies in PLHIV: recent updates and what can they tell us for the future?

TB prevention studies in PLHIV: recent updates and what can they tell us for the future? TB prevention studies in PLHIV: recent updates and what can they tell us for the future? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University TB/HIV Working

More information

ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY JANUARY2012 ISBN X VOL 13(1)

ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY JANUARY2012 ISBN X VOL 13(1) ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY JANUARY2012 ISBN 1595-689X VOL 13(1) AJCEM/201176/21202 -http://www.ajol.info/journals/ajcem COPYRIGHT 2012 AFR. J. CLN. EXPER.

More information

EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD

EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD Original Article 219 EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD M. Gomathi Sekar, Fathima Rehman, Vanaja Kumar and N. Selvakumar (Received on 12.4.2012;

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Kathryn Schnippel 1, Gesine Meyer-Rath 1,2, Lawrence Long 1, Wendy Stevens 3,4, Ian Sanne 1,2, and Sydney Rosen

More information

Jessica Minion 1,2, Erika Leung 1,2, Dick Menzies 1,2, Madhukar Pai 1,2. Contact:

Jessica Minion 1,2, Erika Leung 1,2, Dick Menzies 1,2, Madhukar Pai 1,2. Contact: Microscopically Observed Drug Susceptibility (MODS) and Thin Layer Agar (TLA) assays for the detection of drug resistance in Mycobacterium tuberculosis: A Systematic Review and Meta-analysis Jessica Minion

More information

Treatment of Active Tuberculosis

Treatment of Active Tuberculosis Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest

More information

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Management of MDR TB Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Outline Global epidemiology of Tuberculosis Epidemiology of Tuberculosis

More information

Heather Alexander, PhD

Heather Alexander, PhD Xpert MTB/RIF: An Opportunity to Strengthen Laboratory Systems and Bridge the Laboratory-Program Gap Heather Alexander, PhD International Laboratory Branch Division of Global HIV/AIDS Centers for Disease

More information

Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.

Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System Original Article Clinical Microbiology Ann Lab Med 2012;32:264-269 ISSN 2234-3806 eissn 2234-3814 Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System Won-Jung Koh, M.D. 1,

More information

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens Original Article Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens Jinghui Du 1, Zikun Huang 2, Qing Luo 2, Guoliang Xiong 3, Xiaomeng Xu 2,

More information

Laboratory diagnosis of spinal tuberculosis: Past and Present. SA Patwardhan, S Joshi Abstract : Spinal tuberculosis often has an indolent course and

Laboratory diagnosis of spinal tuberculosis: Past and Present. SA Patwardhan, S Joshi Abstract : Spinal tuberculosis often has an indolent course and Laboratory diagnosis of spinal tuberculosis: Past and Present. SA Patwardhan, S Joshi Abstract : Spinal tuberculosis often has an indolent course and can be a diagnostic challenge. Timely laboratory diagnosis

More information

Role of Xpert MTB/RIF Assay in the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance

Role of Xpert MTB/RIF Assay in the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance Role of Xpert MTB/RIF Assay in the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance Taher Abdel -Aziz 1, Naglaa Azab 2, Eman AboElabass 3 & I.M El-deen 4 1 Ph.D of Biochemistry, Faculty of

More information

ORIGINAL ARTICLE. Department of Microbiology, Military Medical Academy, Belgrade, Yugoslavia. Clin Microbiol Infect 2002; 8:

ORIGINAL ARTICLE. Department of Microbiology, Military Medical Academy, Belgrade, Yugoslavia. Clin Microbiol Infect 2002; 8: ORIGINAL ARTICLE Evaluation of the MB/BacT System for recovery of mycobacteria from clinical specimens in comparison to Lowenstein Jensen medium V. Mirovic and Z. Lepsanovic Department of Microbiology,

More information

New frontiers: Innovation and Access

New frontiers: Innovation and Access 8th Regional TB Symposium Tashkent, Uzbekistan Prof. L.N. Chernousova Central Tuberculosis Research Institute (CTRI) Ministry of Health of the Republic of Uzbekistan 28 February 1 March, 2019 1970 1975

More information